Facilitated our Journal Club today on APPLAUSE-IgAN Trial’s interim analysis.
🔗 www.nejm.org/doi/full/10....
@nyunephro.bsky.social

Exciting times — there is always more to learn & this fellow is here for all of it! 🤓🔬�� #GlomerularDiseases #Nephrology

AKI, high anion gap & osmolal gap, bluish fluorescence under Wood’s lamp, & these crystals I proudly took photos of under the microscope (lol) — interesting day @nyunephro.bsky.social @weddellite.bsky.social ! 💎

#urinemicroscopy #toxicology #nephrology

Presented a case of C3 Glomerulonephritis #C3GN for fellow’s case conference @nyunephro.bsky.social ✨

My favorite photos/diagrams from resources I used — highly educational!👇🏼

📚 www.kidney-international.org/article/S008...
📚 doi.org/10.1016/j.ek...
📚 doi.org/10.1038/s415...

💎 Kidney Stone Time

How to prevent Calcium Phosphate stones in px w/ HYPOcitrinuria but has alkaline urine?

*keeping in mind that alkaline urine increases CaPhos supersaturation*

Expert opinion:
▪️Still, PRESCRIBE CITRATE!
#SaysDrGoldfarb @weddellite.bsky.social

📖 pubmed.ncbi.nlm.nih.gov/22595827

Key takeaway on IgAN management by Dr. Jonathan Barratt @kdigo.org

Goal is to switch off production of pathogenic IgA responsible for nephron loss by using a combination treatment strategy, rather than a sequential approach, to avoid kidney failure within our patients’ lifetimes 💯

Started my morning with excitement after reading an email from @isgd.bsky.social! 🤓

Don’t miss this FREE opportunity to learn from @kdigo.org (we, nephrology fellows, should take advantage! 💸😆)

Register now: gems-gd.org
#nephrology #glomerulardiseases